According to The Medical Diagnostic Ultrasound Market in the USA: Challenges & Opportunities in the New Millennium, 2013 report, the U.S. ultrasound market grew almost 3 percent last year compared to 2012 to reach an all-time high of $1.44 billion.
The U.S. Food and Drug Administration (FDA) granted market clearance to the CardioMEMS Heart Failure System, the first FDA-approved heart failure (HF) monitoring device shown in clinical trials to significantly reduce hospital admissions.
Further validating its advanced transcatheter aortic valve implantation (TAVI) technology, the Boston Scientific Corp. Lotus Valve System continued to demonstrate impressive performance at six months, according to new data presented at EuroPCR 2014 in Paris.
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
Dassault Systèmes the 3DEXPERIENCE Company, world leader in 3-D design software, 3-D Digital Mock Up and Product Lifecycle Management (PLM) solutions, unveiled the world’s first 3-D realistic simulation model of a whole human heart.
A federal grant will support a pilot project designed by two chapters of the American College of Cardiology to reduce health care costs by providing tools to help doctors and patients communicate about options for their care while helping physicians apply the latest guidelines to the decision-making process.
There has been growing clinical evidence to show computed tomography (CT) coronary artery calcium scoring shows a close correlation with a person’s long-term risk for heart disease. This data convinced the American College of Cardiology (ACC) to include CT calcium scoring in its revised guidelines for prevention and cholesterol released last fall. In addition, the ACC highlighted the evidence for CT calcium scoring as a late breaking session at its 63rd Annual Scientific Session in March.
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
As a cardiovascular technology magazine editor, I keep tabs on what technology is in development and often have the opportunity to see the most cutting edge technology up close prior to U.S. Food and Drug Administration (FDA) approval. I discovered there are certain universal truths to consider when reviewing new technology, be it a new device, procedure or IT system.
Direct Flow Medical Inc. announced 12-month outcomes from the DISCOVER CE mark clinical trial.
Biotronik announced that the U.S. Food and Drug Administration (FDA) has approved a significant expansion of its ongoing ProMRI trial.
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
May 27, 2014 — Ekos Corp. announced the U.S. Food and Drug Administration (FDA) has cleared the EkoSonic endovascular system for the ultrasound-facilitated, controlled and selective infusion of physician-specified fluids, including thrombolytics, into the vasculature for the treatment of pulmonary embolism (PE).
May 27, 2014 — New research published in Nature’s Scientific Reports identifies a new type of light sensor that could allow medical and security imaging via low-cost cameras.
The U.S. Food and Drug Administration (FDA)-cleared EKG Glove by IneedMD Inc., based in New York, has been recognized as one of the most cutting edge medical technologies ready to save lives in battlefield situations.
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
Terumo BCT has entered into a business relationship with Kaneka to gain market authorization in the United States for the use of the Terumo BCT Spectra Optia Apheresis System with the Kaneka Liposorber LA-40S LDL Adsorption Column for cardiologists treating patients with high cholesterol.
May 23, 2014 — Stentys presented final results from the APPOSITION IV study of its new self-apposing sirolimus-eluting stent (SES) during the Hotline session at the EuroPCR conference in Paris.
May 23, 2014 — The first drug-eluting balloon to go up for review by the U.S. Food and Drug Administration (FDA) will be discussed at the next Circulatory System Devices Panel of the Medical Devices Advisory Committee on June 12 in Germantown, Md.